The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Study examines impact of two-year screening interval for breast cancer

Except for women in their 40s, women who are screened with mammography every 2 years may not have an increased risk of late-stage breast cancer compared with women screened every year, according to a new study in the December 15 issue of the Journal of the National Cancer Institute.

The ideal interval between screenings for breast cancer using mammography has not been determined. In the United States, the U.S. Preventive Services Task Force recommends screening with mammography every 1 to 2 years, whereas the American Cancer Society recommends annual screening. In Europe, most countries recommend that women be screened every 2 years and concentrate their recommendations on women age 50 and older.

To determine if women screened every 2 years have an increased risk of late-stage breast cancer, Emily White, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, and colleagues conducted an observational study using data collected by seven mammography registries in the United States. They examined whether the 2,440 women who had been diagnosed with breast cancer after receiving biennial screening were more likely to have been diagnosed with late-stage cancer compared with 5,400 women diagnosed with breast cancer after receiving annual screening.

Among women age 50 years or older, there was no increase in the risk of late-stage breast cancer for those who received screening every 2 years compared with those screened annually. There was also no indication that annual screening would benefit women with dense breasts. However, for women in their 40s, those who received biennial screening were more likely to have late-stage disease when they were diagnosed with breast cancer than were those who received annual mammograms (28% versus 21%).

"In summary, we found little evidence that indicates that women who undergo mammography screening every 2 years have an increased risk of late-stage breast cancer compared with women who unde
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
14-Dec-2004


Page: 1 2

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Study examines impact two year screening interval for breast cancer

(Date:11/24/2009)..., FLINT,Mich.,Nov.24/PRNewswire/--HealthPlusofMich...ceplansdesignedspecificallyforindividuals18to64and...thcoveragedirectly. ,, Thenew HealthPlusSignatu...ndthroughagentsandbrokersthroughouttheHealthPlusse...ing,isalsoavailablebytoll-freephonecallto1-877-562...
(Date:11/24/2009)... The molecular cause of inflamm...ch will be presented at the upcoming 2009 Advances... & Colitis Foundation’s Clinical & R...rida, that may identify a causative mutation for C...ew York, NY (Vocus) November 24, 2009 -- The molec...
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/--Whiletheholidayse...te,thistimeoftheyearcanbedifficultforthosegrieving...icultforchildrenandfamilies.Theholidayseasoncanbri... TheHighmarkCaringPlace,ACenterforGrievingChildren...oneedsupport.Inadditiontohavingavarietyofprintando...
(Date:11/24/2009)..., BIRMINGHAM,Ala.,Nov.24/PRNewswire-FirstCall/--He...llparticipateintheBankofAmericaMerrillLynch2009Cre...SouthSeniorVicePresidentandTreasurerEdFaywillbespe...ationwillbewebcastliveandwillbeavailableat http://...nk. ,, AboutHealthSouth ,, HealthSouthisth...
(Date:11/24/2009)...pital death rates didn,t differ greatly between hi... , TUESDAY, Nov. 24 (HealthDay News) -- Do hospit...y produce the best results for patients? Maybe not... makes perfect" when it comes to artery-opening pr...tients finds low- and high-volume hospitals perfor...
Breaking Medicine News(10 mins):Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
(Date:11/24/2009)...sciencesCorporationannouncedtodaythattherewillbemu...erationFLT3inhibitor,inAMLatthe51stAmericanSociety...,LA,December5-8,2009.Anoralpresentationwillhighlig...etystudyinadultswithacutemyeloidleukemia(AML).Addi...theeffectofAC220monotherapyandincombinationwithche...
(Date:11/24/2009)...tCall/--EchoTherapeutics,Inc.(OTCBulletinBoard:ECT...MSystemasanon-invasive,wireless,transdermalcontinu...kinPrepSystemfortransdermaldrugdelivery,announcedt...tiveOfficer,willpresentatthe13thAnnualBiotechandSp...YorkSocietyofSecuritiesAnalysts,at2:05onDecember1,...
(Date:11/24/2009)...CardiovascularLLC,aleadingproviderofcardiovascular...eedtwo-yearcontractwithNovation,oneofthenation,sla...eproviderofsurgicaldevicesforbeatingheartcardiacsu...throughOctober31,2012,MAQUETCardiovascularwillbeth...lesuppliestothemembersofVHAInc.andUniversityHealth...
Breaking Medicine Technology:Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Bioniche Pharma Acquires Duraclon 28R 29 28clonidine hydrochloride injection 29 and Methadone Hydrochloride Injection USP 61269 1Bioniche Pharma Acquires Duraclon 28R 29 28clonidine hydrochloride injection 29 and Methadone Hydrochloride Injection USP 61269 2BioMS Medical Announces Third Quarter 2009 Results 14817 1BioMS Medical Announces Third Quarter 2009 Results 14817 2BioMS Medical Announces Third Quarter 2009 Results 14817 3BioMS Medical Announces Third Quarter 2009 Results 14817 4BioMS Medical Announces Third Quarter 2009 Results 14817 5BioMS Medical Announces Third Quarter 2009 Results 14817 6BioMS Medical Announces Third Quarter 2009 Results 14817 7BioMS Medical Announces Third Quarter 2009 Results 14817 8EF Johnson Technologies Announces Third Quarter Results 6230 1EF Johnson Technologies Announces Third Quarter Results 6230 2EF Johnson Technologies Announces Third Quarter Results 6230 3EF Johnson Technologies Announces Third Quarter Results 6230 4EF Johnson Technologies Announces Third Quarter Results 6230 5EF Johnson Technologies Announces Third Quarter Results 6230 6EF Johnson Technologies Announces Third Quarter Results 6230 7EF Johnson Technologies Announces Third Quarter Results 6230 8
Other News:
...rent brain systems that can enhance both the pleas...s, according to new research studies with rats. Th...ddicted to drugs while others do not, the scientis... on two parallel, but opposing brain circuits........
...ia School of Medicine researchers have identified ...hen produced in mice, dramatically reduces symptom... possibility of new treatment options for sickle c...Assistant Professor of Medicine and Pediatrics, an...
...n Increased Risk of Death from All Causes...Consum...ased Mortality Risk for These Patients ...Analyzin...and Nutrition Examination Surveys, Mainous and col...errin saturation, an indicator of a predisposition...
...red that a nearly identical version of a gene whos...in humans is a key component of the song-learning ...published their findings in the March 31, 2004, is...r finding will aid research on how genes contribut...
health news:Single cocaine exposure boosts both drug craving and avoidance 2health news:Single cocaine exposure boosts both drug craving and avoidance 3health news:New therapeutic approach for sickle cell disease 2health news:March/April 2004 Annals of Family Medicine tip sheet 2health news:March/April 2004 Annals of Family Medicine tip sheet 3health news:March/April 2004 Annals of Family Medicine tip sheet 4health news:March/April 2004 Annals of Family Medicine tip sheet 5health news:March/April 2004 Annals of Family Medicine tip sheet 6health news:A bird 'language' gene pinpointed 2health news:A bird 'language' gene pinpointed 3health news:A bird 'language' gene pinpointed 4
... a new study in American Journal of Transplantatio...a, a treatable blood deficiency, are more likely t...splant recipients.... "During a four year period f...mic patients were 70 percent more likely to die fo...
...how Earth observation satellites can assist in the... and animal welfare standards that farmers have to... Union included in the 2003 reforms of the Common...n (VHR) satellite images for monitoring whether la...
...3 April) launch a new research partnership to inve... sport, physical activity and long-term participat...archers Dr Christine Paul and Dr Erica James, is f...rt of the organisations further commitment to redu...
LOS ANGELES -- Mayo Clinic Cancer Center researchers have found that chaetocin, a by-product of a common wood mold, has promise as a new anti-myeloma agent. Results of their study, being presented to
health news:Satellite images aid implementation of agricultural reforms 2health news:Sporting research aims to reduce childhood obesity 2health news:Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma 2